CXCL10 and cancer: Evidence is emerging to support the concept that these cells are epigenetically reprogramed so that a group of antifibrotic genes, including COX-2, Thy-1, and IP-10, are epigenetically silenced in a way similar to the epigenetic silencing of tumor suppressor genes in cancers.